Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Harada

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Hemasphere|July 14, 2025
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka, et al.
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2022
[Klinefelter's syndrome diagnosed at the onset of acute myeloid leukemia with inv (16) following treatment for germ cell tumor]Kisa Tanabe, Yuho Najima, Takuhiko Inokuchi, et al.
Leukemia Research|April 30, 2025
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adultsKaori Kondo, Yuho Najima, Daichi Sadato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis]Kairi Kojo, Yuho Najima, Kyoko Haraguchi, et al.
Cell Reports|March 2, 2023
The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesisNaoki Ikeda, Hiroaki Kubota, Risa Suzuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]Kazuya Kurihara, Daichi Sadato, Yuho Najima, et al.
Nature Communications|November 28, 2025
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndromeMotohiko Oshima, Naoya Takayama, Yaeko Nakajima-Takagi, et al.
Nature Communications|August 28, 2024
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilizationSatoshi Kaito, Kazumasa Aoyama, Motohiko Oshima, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Hemasphere|July 14, 2025
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka, et al.
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2022
[Klinefelter's syndrome diagnosed at the onset of acute myeloid leukemia with inv (16) following treatment for germ cell tumor]Kisa Tanabe, Yuho Najima, Takuhiko Inokuchi, et al.
Leukemia Research|April 30, 2025
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adultsKaori Kondo, Yuho Najima, Daichi Sadato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis]Kairi Kojo, Yuho Najima, Kyoko Haraguchi, et al.
Cell Reports|March 2, 2023
The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesisNaoki Ikeda, Hiroaki Kubota, Risa Suzuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]Kazuya Kurihara, Daichi Sadato, Yuho Najima, et al.
Nature Communications|November 28, 2025
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndromeMotohiko Oshima, Naoya Takayama, Yaeko Nakajima-Takagi, et al.
Nature Communications|August 28, 2024
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilizationSatoshi Kaito, Kazumasa Aoyama, Motohiko Oshima, et al.
Pageof 13